Emily Randall sells stocks in multiple companies including Abbott Laboratories and Alphabet Inc.

EditorFrank DeMatteo
Published 02/13/2025, 05:42 AM
Emily Randall sells stocks in multiple companies including Abbott Laboratories and Alphabet Inc.

Emily Randall, the congresswoman representing Washington’s 6th congressional district, has recently sold stocks in a range of companies, according to a congressional trade report. The transactions were made from a Garret D. Leahey 2019 Irrevocable trust, benefiting Alison Leahey.

The report indicates that the transactions were made in January 2025 and notified in February 2025. The companies from which stocks were sold include Abbott Laboratories (NYSE:ABT), a prominent healthcare equipment company that has maintained dividend payments for 55 consecutive years and operates with moderate debt levels, Alphabet (NASDAQ:GOOGL) Inc. - Class C Capital Stock (NASDAQ:GOOG), Amgen Inc . - Common Stock (NASDAQ:AMGN), Exxon Mobil Corporation Common Stock (NYSE:XOM), and Fortive Corporation Common Stock (NYSE:FTV).

Each of these transactions fell within the $1,001 - $15,000 range. The report does not indicate whether the transactions resulted in capital gains exceeding $200.

Additional transactions were made with Medtronic plc. Ordinary Shares (NYSE:MDT), Mondelez International, Inc. - Class A Common Stock (NASDAQ:MDLZ), Pepsico , Inc. (NASDAQ:PEP), Procter & Gamble Company (NYSE:PG), Verizon Communications Inc. Common Stock (NYSE:VZ), and Wells Fargo & Company Common Stock (NYSE:WFC). Each of these transactions also fell within the $1,001 - $15,000 range.

The congresswoman’s transactions highlight the active role she is playing in managing her investments. As these transactions are part of an irrevocable trust, they are likely part of a long-term financial strategy. Notable among these is Abbott Laboratories, which according to InvestingPro analysis, has shown strong returns over the last decade and maintains a solid dividend history. Investors should note these transactions as they provide insight into the investment activities of a prominent congresswoman.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.